Kezar Life Sciences Inc.
05/14/2026 | Press release | Distributed by Public on 05/15/2026 04:19
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 14, 2026 |
| Accession Number: | 0001140361-26-020547 | ||||||
| Submission Type: | POS AM | ||||||
|
|||||||
Kezar Life Sciences Inc. published this content on May 14, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on May 15, 2026 at 10:19 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]